Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3711082012 | Olanzapine-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711083019 | Product containing olanzapine in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4665571000052110 | läkemedel som innehåller olanzapin, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olanzapine-containing product in parenteral dose form | Is a | Product containing olanzapine (medicinal product) | true | Inferred relationship | Some | ||
| Olanzapine-containing product in parenteral dose form | Has active ingredient | Olanzapine (substance) | true | Inferred relationship | Some | 1 | |
| Olanzapine-containing product in parenteral dose form | Has active ingredient | atypiskt antipsykotiskt medel | false | Inferred relationship | Some | ||
| Olanzapine-containing product in parenteral dose form | Has manufactured dose form | för injektion | false | Inferred relationship | Some | ||
| Olanzapine-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Olanzapine-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| olanzapin 10 mg, pulver till injektionsvätska | Is a | False | Olanzapine-containing product in parenteral dose form | Inferred relationship | Some | |
| olanzapin 210 mg, pulver till injektionsvätska | Is a | False | Olanzapine-containing product in parenteral dose form | Inferred relationship | Some | |
| olanzapin 300 mg, pulver till injektionsvätska | Is a | False | Olanzapine-containing product in parenteral dose form | Inferred relationship | Some | |
| olanzapin 405 mg, pulver till injektionsvätska, suspension | Is a | False | Olanzapine-containing product in parenteral dose form | Inferred relationship | Some | |
| Olanzapine only product in parenteral dose form | Is a | True | Olanzapine-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR